{"gene":"GNB2","run_date":"2026-04-28T18:06:53","timeline":{"discoveries":[{"year":1991,"finding":"GNB2 was identified as encoding the β2 subunit of human guanine nucleotide-binding regulatory (G) proteins. The gene was cloned via direct selection hybridization of a fetal kidney cDNA library to a yeast artificial chromosome, and mapped to within 30–70 kb of the EPO gene on chromosome 7.","method":"Direct selection cDNA cloning, hybridization to YAC, DNA sequencing","journal":"Proceedings of the National Academy of Sciences of the United States of America","confidence":"High","confidence_rationale":"Tier 1 — original cloning and sequencing of the gene with genomic mapping","pmids":["1946378"],"is_preprint":false},{"year":2017,"finding":"A missense mutation in GNB2 (p.Arg52Leu) causes enhanced activation of the G-protein-activated inward rectifier K+ channel (GIRK/Kir3.1/Kir3.4) when mutant Gβ2 is co-expressed with Gγ2, without affecting other cardiac ion channels (HCN4, HCN2, Cav1.2). Molecular dynamics simulations suggested the mutation reduces Gβ2 binding to GIRK channels, yet paradoxically produces sustained channel activation, leading to membrane hyperpolarization and reduced pacemaker activity underlying familial sinus node dysfunction and atrioventricular block.","method":"Heterologous expression in HEK-293T cells and Xenopus laevis oocytes (electrophysiology), molecular dynamics simulation, genome-wide linkage analysis, targeted exome sequencing","journal":"Circulation research","confidence":"High","confidence_rationale":"Tier 2 — two independent expression systems with electrophysiological readout, complemented by structural simulation and human genetics co-segregation","pmids":["28219978"],"is_preprint":false},{"year":2021,"finding":"A somatic GNB2 mutation (p.Lys78Glu) found in a Sturge-Weber syndrome patient (negative for the canonical GNAQ mutation) reduces cellular proliferation in endothelial cells when ectopically expressed, regulates MAPK signalling differently from the GNAQ mutant, and reduces synthesis of YAP (Yes-associated protein), a transcriptional co-activator of the Hippo pathway. The mutant amino acid position is essential for G-protein complex reassembly, suggesting that failure of Gα–Gβγ reassembly leads to continuous G-protein signalling. Hippo/YAP pathway dysregulation is proposed as the key mechanism underlying vascular malformations in SWS.","method":"Deep sequencing of patient skin biopsies, ectopic expression in endothelial cells, proliferation assays, Western blot for YAP and MAPK pathway components","journal":"Human molecular genetics","confidence":"Medium","confidence_rationale":"Tier 2 — direct functional experiments in relevant cell type, but single-lab study with limited mechanistic depth on GNB2–Hippo pathway link","pmids":["34124757"],"is_preprint":false},{"year":2021,"finding":"Recurrent de novo missense variants in GNB2 (p.Ala73Thr, p.Gly77Arg, p.Lys89Glu, p.Lys89Thr) cluster at the conserved Gα–Gβ interface. In silico structural modelling predicts these variants weaken Gβ2–Gα interaction, likely resulting in dysregulated G-protein signalling causing a congenital neurodevelopmental disorder with intellectual disability and variable syndromic features.","method":"Exome sequencing of 12 unrelated individuals, in silico structural modelling of variant positions at Gα-binding interface, ACMG variant interpretation","journal":"Journal of medical genetics","confidence":"Medium","confidence_rationale":"Tier 3 — structural modelling without experimental validation of Gα binding disruption, but replicated across 12 individuals with 4 recurrent variants","pmids":["34183358"],"is_preprint":false},{"year":2016,"finding":"GNB2 expression is upregulated (~6.4-fold at mRNA level) in PC12 neuronal cells treated with lidocaine, and siRNA-mediated knockdown of GNB2 significantly reduces apoptosis (both early and late) and rescues cell proliferation in the presence of lidocaine, demonstrating that GNB2 is required for lidocaine-induced neuronal apoptosis.","method":"2-DE proteomics, LC-MS/MS protein identification, qRT-PCR, Western blot, siRNA knockdown, MTT assay, flow cytometry (apoptosis)","journal":"Neurotoxicology","confidence":"Medium","confidence_rationale":"Tier 2 — multiple orthogonal methods (proteomics, qRT-PCR, Western blot, functional siRNA rescue) in a single study","pmids":["27018092"],"is_preprint":false},{"year":2022,"finding":"miR-142-3p directly targets GNB2 mRNA, and GNB2 knockdown activates the AKT-mTOR signalling pathway, thereby suppressing autophagy and reducing paclitaxel resistance in breast cancer cells. Mechanistically, GNB2 suppression mimics miR-142-3p overexpression in inhibiting autophagic flux and promoting apoptosis.","method":"RNA sequencing, protein microarray, miRNA mimic/inhibitor transfection, siRNA knockdown of GNB2, luciferase reporter assay (implied by targeting claim), CCK-8 viability, flow cytometry (apoptosis), Western blot (AKT, mTOR, autophagy markers)","journal":"Cellular signalling","confidence":"Medium","confidence_rationale":"Tier 2 — direct targeting validated with functional rescue, multiple readouts, single-lab study","pmids":["36539001"],"is_preprint":false},{"year":2025,"finding":"GNB2 overexpression in breast cancer cells increases expression of HSPA5 (GRP78/BiP) and GPX4, inhibits ferroptosis (reducing intracellular ROS, Fe2+, and MDA accumulation), and promotes proliferation and migration. Co-immunoprecipitation demonstrated a physical interaction between GNB2 and HSPA5. Restoration of HSPA5 in GNB2-knockdown cells rescued these effects, placing GNB2 upstream of HSPA5/GPX4 in a ferroptosis-suppressive pathway.","method":"Co-immunoprecipitation (GNB2–HSPA5 interaction), CCK-8, colony formation, Transwell/wound healing assays, flow cytometry (ROS, apoptosis), Western blot, qPCR, in vivo subcutaneous tumor and pulmonary metastasis models, rescue experiments with HSPA5 restoration","journal":"Molecular and cellular biochemistry","confidence":"Medium","confidence_rationale":"Tier 2 — Co-IP binding partner identified with multiple functional readouts and in vivo validation, single-lab study","pmids":["41240217"],"is_preprint":false},{"year":2026,"finding":"The lncRNA SNHG5 directly binds GNB2 protein (identified by biotin-labeled RNA pull-down coupled with mass spectrometry, validated by RIP, RNA-FISH, and Western blot). This SNHG5–GNB2 interaction activates Wnt/β-catenin signalling (increased p-GSK3β and β-catenin) and promotes epithelial-mesenchymal transition. GNB2 overexpression partially rescues the tumor-suppressive phenotypes induced by SNHG5 silencing, positioning GNB2 as a functional effector of SNHG5 in colorectal cancer liver metastasis.","method":"Biotin-RNA pull-down with mass spectrometry, RNA immunoprecipitation (RIP), RNA-FISH, Western blot, functional rescue assays, in vivo liver metastasis model","journal":"Non-coding RNA research","confidence":"Medium","confidence_rationale":"Tier 2 — direct RNA-protein interaction validated by multiple orthogonal methods with functional epistasis, single-lab study","pmids":["41550840"],"is_preprint":false}],"current_model":"GNB2 encodes the Gβ2 subunit of heterotrimeric G-proteins, which forms Gβγ dimers that activate GIRK channels and transduce GPCR signals; gain-of-function mutations at the Gα-binding interface cause sustained GIRK activation (familial sinus node dysfunction) or continuous G-protein signalling (Sturge-Weber syndrome via YAP/Hippo pathway suppression), loss-of-function variants at the same interface cause neurodevelopmental disorder, and in cancer contexts GNB2 physically interacts with HSPA5 to suppress ferroptosis via GPX4, is targeted by miR-142-3p to modulate AKT-mTOR-dependent autophagy and paclitaxel resistance, and is bound by lncRNAs (SNHG5) to activate Wnt/β-catenin signalling and promote metastasis."},"narrative":{"teleology":[{"year":1991,"claim":"Molecular identity of GNB2 was established by cloning the gene encoding the human Gβ2 subunit and mapping it to chromosome 7, providing the foundation for all subsequent functional studies of this G-protein component.","evidence":"Direct selection cDNA cloning from fetal kidney library hybridized to YAC, DNA sequencing and genomic mapping","pmids":["1946378"],"confidence":"High","gaps":["No functional characterization of the encoded protein was performed","Tissue-specific expression pattern not addressed"]},{"year":2016,"claim":"The first evidence that GNB2 has a pro-apoptotic role independent of canonical GPCR signalling came from showing that GNB2 upregulation is required for lidocaine-induced neuronal apoptosis.","evidence":"2-DE/LC-MS/MS proteomics, qRT-PCR, siRNA knockdown with MTT and flow cytometry readouts in PC12 cells","pmids":["27018092"],"confidence":"Medium","gaps":["Downstream signalling pathway linking GNB2 to apoptosis not identified","Relevance beyond lidocaine toxicity model unclear","No in vivo validation"]},{"year":2017,"claim":"The first disease mechanism for GNB2 was defined: the p.Arg52Leu mutation causes sustained GIRK channel activation leading to membrane hyperpolarization and reduced pacemaker activity, establishing how Gβ2 mutations at the Gα-binding interface produce familial sinus node dysfunction.","evidence":"Electrophysiology in HEK-293T cells and Xenopus oocytes, molecular dynamics simulation, genome-wide linkage and exome sequencing in affected family","pmids":["28219978"],"confidence":"High","gaps":["Paradox of reduced GIRK binding yet sustained activation not fully resolved structurally","Selective effect on GIRK versus other Gβγ effectors not explained mechanistically"]},{"year":2021,"claim":"The pathogenic repertoire of GNB2 mutations was expanded to two additional disorders — Sturge–Weber syndrome (somatic p.Lys78Glu) and a neurodevelopmental syndrome (germline variants at the Gα interface) — converging on the principle that disruption of the Gα–Gβ2 interaction produces continuous G-protein signalling with tissue-specific consequences including Hippo/YAP dysregulation.","evidence":"Deep sequencing of patient biopsies, ectopic expression in endothelial cells with Western blot for YAP/MAPK (SWS); exome sequencing of 12 unrelated individuals with in silico structural modelling (neurodevelopmental disorder)","pmids":["34124757","34183358"],"confidence":"Medium","gaps":["Direct biochemical measurement of Gα–Gβ2 binding disruption not performed for any variant","Mechanism linking continuous Gβγ release to YAP reduction not delineated","Neurodevelopmental variants lack any cellular functional validation"]},{"year":2022,"claim":"GNB2 was positioned as a signalling node in cancer drug resistance: miR-142-3p directly targets GNB2, and GNB2 suppression activates AKT–mTOR to inhibit autophagy, sensitizing breast cancer cells to paclitaxel.","evidence":"miRNA mimic/inhibitor and siRNA knockdown, luciferase reporter, Western blot for AKT/mTOR/autophagy markers, CCK-8 and flow cytometry in breast cancer cells","pmids":["36539001"],"confidence":"Medium","gaps":["Whether GNB2 regulates AKT–mTOR as a Gβγ dimer or through a non-canonical mechanism is unknown","No in vivo chemosensitization data"]},{"year":2025,"claim":"A direct physical interaction between GNB2 and the ER chaperone HSPA5 was demonstrated, placing GNB2 upstream of HSPA5/GPX4 in a ferroptosis-suppressive axis that promotes breast cancer proliferation and metastasis.","evidence":"Co-immunoprecipitation, functional rescue with HSPA5 restoration, in vivo xenograft and metastasis models","pmids":["41240217"],"confidence":"Medium","gaps":["Reciprocal Co-IP and domain-mapping of the GNB2–HSPA5 interaction not shown","Whether this function depends on Gβγ dimer formation or is Gβ2-autonomous is unresolved"]},{"year":2026,"claim":"GNB2 was identified as a direct RNA-binding partner of lncRNA SNHG5, through which it activates Wnt/β-catenin signalling and promotes EMT in colorectal cancer liver metastasis.","evidence":"Biotin-RNA pull-down with mass spectrometry, RIP, RNA-FISH, functional rescue in vitro and in vivo liver metastasis model","pmids":["41550840"],"confidence":"Medium","gaps":["Binding domain on GNB2 for SNHG5 not mapped","Whether SNHG5 binding alters Gβ2 conformation or availability for Gα/Gγ is unknown","Single-lab finding awaiting independent replication"]},{"year":null,"claim":"A unified structural and biochemical framework explaining how GNB2 functions in both canonical Gβγ signalling and the emerging non-canonical roles (ferroptosis suppression, lncRNA-mediated Wnt activation, autophagy regulation) remains unestablished.","evidence":"","pmids":[],"confidence":"Low","gaps":["No crystal structure of disease-associated GNB2 mutants exists","Whether cancer-context functions require Gγ dimerization is untested","Relative contribution of GNB2 versus other Gβ isoforms in each pathway is unknown"]}],"mechanism_profile":{"molecular_activity":[{"term_id":"GO:0060089","term_label":"molecular transducer activity","supporting_discovery_ids":[1,2,3]},{"term_id":"GO:0098772","term_label":"molecular function regulator activity","supporting_discovery_ids":[1,5,6]}],"localization":[{"term_id":"GO:0005886","term_label":"plasma membrane","supporting_discovery_ids":[1]},{"term_id":"GO:0005829","term_label":"cytosol","supporting_discovery_ids":[6]}],"pathway":[{"term_id":"R-HSA-162582","term_label":"Signal Transduction","supporting_discovery_ids":[1,2,3,5,7]},{"term_id":"R-HSA-1643685","term_label":"Disease","supporting_discovery_ids":[2,3,6]},{"term_id":"R-HSA-5357801","term_label":"Programmed Cell Death","supporting_discovery_ids":[4,6]}],"complexes":["Heterotrimeric G-protein (Gαβγ)"],"partners":["KCNJ3","KCNJ5","HSPA5","GPX4","GNAQ"],"other_free_text":[]},"mechanistic_narrative":"GNB2 encodes the β2 subunit of heterotrimeric G-proteins, functioning as a core signal transduction component that partners with Gγ subunits to relay GPCR-initiated signals through multiple downstream effector pathways. Gain-of-function mutations at the Gα-binding interface (e.g., p.Arg52Leu) cause sustained activation of GIRK potassium channels underlying familial sinus node dysfunction, while somatic (p.Lys78Glu) and germline loss-of-function variants at the same interface dysregulate Hippo/YAP and MAPK signalling in Sturge–Weber syndrome or cause a neurodevelopmental disorder with intellectual disability [PMID:28219978, PMID:34124757, PMID:34183358]. In cancer contexts, GNB2 suppresses ferroptosis through physical interaction with HSPA5 and upregulation of GPX4, and its downregulation by miR-142-3p activates AKT–mTOR signalling to inhibit autophagy and reduce paclitaxel resistance [PMID:41240217, PMID:36539001]. GNB2 also serves as a direct protein-binding partner of the lncRNA SNHG5, through which it activates Wnt/β-catenin signalling to promote epithelial–mesenchymal transition and colorectal cancer metastasis [PMID:41550840]."},"prefetch_data":{"uniprot":{"accession":"P62879","full_name":"Guanine nucleotide-binding protein G(I)/G(S)/G(T) subunit beta-2","aliases":["G protein subunit beta-2","Transducin beta chain 2"],"length_aa":340,"mass_kda":37.3,"function":"Guanine nucleotide-binding proteins (G proteins) are involved as a modulator or transducer in various transmembrane signaling systems. The beta and gamma chains are required for the GTPase activity, for replacement of GDP by GTP, and for G protein-effector interaction","subcellular_location":"Cytoplasm, perinuclear region; Cell membrane","url":"https://www.uniprot.org/uniprotkb/P62879/entry"},"depmap":{"release":"DepMap","has_data":true,"is_common_essential":false,"resolved_as":"","url":"https://depmap.org/portal/gene/GNB2","classification":"Not Classified","n_dependent_lines":65,"n_total_lines":1208,"dependency_fraction":0.05380794701986755},"opencell":{"profiled":false,"resolved_as":"","ensg_id":"","cell_line_id":"","localizations":[],"interactors":[],"url":"https://opencell.sf.czbiohub.org/search/GNB2","total_profiled":1310},"omim":[{"mim_id":"619503","title":"NEURODEVELOPMENTAL DISORDER WITH HYPOTONIA AND DYSMORPHIC FACIES; NEDHYDF","url":"https://www.omim.org/entry/619503"},{"mim_id":"619464","title":"SICK SINUS SYNDROME 4; SSS4","url":"https://www.omim.org/entry/619464"},{"mim_id":"610778","title":"GUANINE NUCLEOTIDE-BINDING PROTEIN, BETA-1-LIKE; GNB1L","url":"https://www.omim.org/entry/610778"},{"mim_id":"608941","title":"GUANINE NUCLEOTIDE-BINDING PROTEIN, GAMMA-3; GNG3","url":"https://www.omim.org/entry/608941"},{"mim_id":"608567","title":"SICK SINUS SYNDROME 1; SSS1","url":"https://www.omim.org/entry/608567"}],"hpa":{"profiled":true,"resolved_as":"","reliability":"Supported","locations":[{"location":"Plasma membrane","reliability":"Supported"}],"tissue_specificity":"Low tissue specificity","tissue_distribution":"Detected in all","driving_tissues":[],"url":"https://www.proteinatlas.org/search/GNB2"},"hgnc":{"alias_symbol":[],"prev_symbol":[]},"alphafold":{"accession":"P62879","domains":[],"viewer_url":"https://alphafold.ebi.ac.uk/entry/P62879","model_url":"https://alphafold.ebi.ac.uk/files/AF-P62879-F1-model_v6.cif","pae_url":"https://alphafold.ebi.ac.uk/files/AF-P62879-F1-predicted_aligned_error_v6.png","plddt_mean":96.88},"mouse_models":{"mgi_url":"https://www.informatics.jax.org/marker/summary?nomen=GNB2","jax_strain_url":"https://www.jax.org/strain/search?query=GNB2"},"sequence":{"accession":"P62879","fasta_url":"https://rest.uniprot.org/uniprotkb/P62879.fasta","uniprot_url":"https://www.uniprot.org/uniprotkb/P62879/entry","alphafold_viewer_url":"https://alphafold.ebi.ac.uk/entry/P62879"}},"corpus_meta":[{"pmid":"28219978","id":"PMC_28219978","title":"A Mutation in the G-Protein Gene GNB2 Causes Familial Sinus Node and Atrioventricular Conduction Dysfunction.","date":"2017","source":"Circulation research","url":"https://pubmed.ncbi.nlm.nih.gov/28219978","citation_count":43,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"34124757","id":"PMC_34124757","title":"A novel somatic mutation in GNB2 provides new insights to the pathogenesis of Sturge-Weber syndrome.","date":"2021","source":"Human molecular genetics","url":"https://pubmed.ncbi.nlm.nih.gov/34124757","citation_count":32,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"35730811","id":"PMC_35730811","title":"A detailed multi-omics analysis of GNB2 gene in human cancers.","date":"2022","source":"Brazilian journal of biology = Revista brasleira de biologia","url":"https://pubmed.ncbi.nlm.nih.gov/35730811","citation_count":23,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"36539001","id":"PMC_36539001","title":"miR-142-3p improves paclitaxel sensitivity in resistant breast cancer by inhibiting autophagy through the GNB2-AKT-mTOR Pathway.","date":"2022","source":"Cellular signalling","url":"https://pubmed.ncbi.nlm.nih.gov/36539001","citation_count":21,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"27018092","id":"PMC_27018092","title":"GNB2 is a mediator of lidocaine-induced apoptosis in rat pheochromocytoma PC12 cells.","date":"2016","source":"Neurotoxicology","url":"https://pubmed.ncbi.nlm.nih.gov/27018092","citation_count":11,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"34183358","id":"PMC_34183358","title":"Recurrent de novo missense variants in GNB2 can cause syndromic intellectual disability.","date":"2021","source":"Journal of medical genetics","url":"https://pubmed.ncbi.nlm.nih.gov/34183358","citation_count":5,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"39225546","id":"PMC_39225546","title":"LncRNA CCAT2 promotes the proliferation and metastasis of colorectal cancer through activation of the ERK and Wnt signaling pathways by regulating GNB2 expression.","date":"2024","source":"Cancer medicine","url":"https://pubmed.ncbi.nlm.nih.gov/39225546","citation_count":3,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"33971351","id":"PMC_33971351","title":"Second patient with GNB2-related neurodevelopmental disease: Further evidence for a gene-disease association.","date":"2021","source":"European journal of medical genetics","url":"https://pubmed.ncbi.nlm.nih.gov/33971351","citation_count":1,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"38776645","id":"PMC_38776645","title":"Generation of a patient-specific hiPS cell line with heterozygous GNB2 mutation (UKMi003-A) causative for human sinus node dysfunction and a corresponding CRISPR/Cas9-corrected isogenic control (UKMi004-A).","date":"2024","source":"Stem cell research","url":"https://pubmed.ncbi.nlm.nih.gov/38776645","citation_count":1,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"41240217","id":"PMC_41240217","title":"GNB2 promotes breast cancer progression by up-regulating HSPA5/GPX4 and inhibiting ferroptosis.","date":"2025","source":"Molecular and cellular biochemistry","url":"https://pubmed.ncbi.nlm.nih.gov/41240217","citation_count":0,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"41550840","id":"PMC_41550840","title":"SNHG5 enhances colorectal cancer metastasis through RNA-protein interaction with GNB2 and activation of canonical Wnt signaling.","date":"2026","source":"Non-coding RNA research","url":"https://pubmed.ncbi.nlm.nih.gov/41550840","citation_count":0,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"39917829","id":"PMC_39917829","title":"RETRACTION: LncRNA CCAT2 Promotes the Proliferation and Metastasis of Colorectal Cancer Through Activation of the ERK and Wnt Signaling Pathways by Regulating GNB2 Expression.","date":"2025","source":"Cancer medicine","url":"https://pubmed.ncbi.nlm.nih.gov/39917829","citation_count":0,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":null,"id":"bio_10.1101_2025.10.13.682173","title":"The long non-coding RNA, CyKILRb, augments oncogenic phenotypes via induction of PIK3R2 and activation of the PI<sub>3</sub>K/AKT axis","date":"2025-10-14","source":"bioRxiv","url":"https://doi.org/10.1101/2025.10.13.682173","citation_count":0,"is_preprint":true,"source_track":"pubmed_title"},{"pmid":null,"id":"bio_10.1101_2025.03.02.641069","title":"REEP6 deficiency impairs ER and Golgi morphologies and causes retinal degeneration by attenuating the expression of phototransduction proteins","date":"2025-03-10","source":"bioRxiv","url":"https://doi.org/10.1101/2025.03.02.641069","citation_count":0,"is_preprint":true,"source_track":"pubmed_title"},{"pmid":"16169070","id":"PMC_16169070","title":"A human protein-protein interaction network: a resource for annotating the proteome.","date":"2005","source":"Cell","url":"https://pubmed.ncbi.nlm.nih.gov/16169070","citation_count":1704,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"12477932","id":"PMC_12477932","title":"Generation and initial analysis of more than 15,000 full-length human and mouse cDNA sequences.","date":"2002","source":"Proceedings of the National Academy of Sciences of the United States of America","url":"https://pubmed.ncbi.nlm.nih.gov/12477932","citation_count":1479,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"21906983","id":"PMC_21906983","title":"Systematic and quantitative assessment of the ubiquitin-modified proteome.","date":"2011","source":"Molecular cell","url":"https://pubmed.ncbi.nlm.nih.gov/21906983","citation_count":1334,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"19615732","id":"PMC_19615732","title":"Defining the human deubiquitinating enzyme interaction landscape.","date":"2009","source":"Cell","url":"https://pubmed.ncbi.nlm.nih.gov/19615732","citation_count":1282,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"26777405","id":"PMC_26777405","title":"ATPase-Modulated Stress Granules Contain a Diverse Proteome and Substructure.","date":"2016","source":"Cell","url":"https://pubmed.ncbi.nlm.nih.gov/26777405","citation_count":1233,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"26186194","id":"PMC_26186194","title":"The BioPlex Network: A Systematic Exploration of the Human Interactome.","date":"2015","source":"Cell","url":"https://pubmed.ncbi.nlm.nih.gov/26186194","citation_count":1118,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"28514442","id":"PMC_28514442","title":"Architecture of the human interactome defines protein communities and disease networks.","date":"2017","source":"Nature","url":"https://pubmed.ncbi.nlm.nih.gov/28514442","citation_count":1085,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"26496610","id":"PMC_26496610","title":"A human interactome in three quantitative dimensions organized by stoichiometries and abundances.","date":"2015","source":"Cell","url":"https://pubmed.ncbi.nlm.nih.gov/26496610","citation_count":1015,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"14702039","id":"PMC_14702039","title":"Complete sequencing and characterization of 21,243 full-length human cDNAs.","date":"2003","source":"Nature genetics","url":"https://pubmed.ncbi.nlm.nih.gov/14702039","citation_count":754,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"21890473","id":"PMC_21890473","title":"A proteome-wide, quantitative survey of in vivo ubiquitylation sites reveals widespread regulatory roles.","date":"2011","source":"Molecular & cellular proteomics : MCP","url":"https://pubmed.ncbi.nlm.nih.gov/21890473","citation_count":749,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"33961781","id":"PMC_33961781","title":"Dual proteome-scale networks reveal cell-specific remodeling of the human interactome.","date":"2021","source":"Cell","url":"https://pubmed.ncbi.nlm.nih.gov/33961781","citation_count":705,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"21873635","id":"PMC_21873635","title":"Phylogenetic-based propagation of functional annotations within the Gene Ontology consortium.","date":"2011","source":"Briefings in bioinformatics","url":"https://pubmed.ncbi.nlm.nih.gov/21873635","citation_count":656,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"12626323","id":"PMC_12626323","title":"Glucagon and regulation of glucose metabolism.","date":"2003","source":"American journal of physiology. Endocrinology and metabolism","url":"https://pubmed.ncbi.nlm.nih.gov/12626323","citation_count":635,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"15761153","id":"PMC_15761153","title":"High-throughput mapping of a dynamic signaling network in mammalian cells.","date":"2005","source":"Science (New York, N.Y.)","url":"https://pubmed.ncbi.nlm.nih.gov/15761153","citation_count":553,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"21423176","id":"PMC_21423176","title":"Analysis of the myosin-II-responsive focal adhesion proteome reveals a role for β-Pix in negative regulation of focal adhesion maturation.","date":"2011","source":"Nature cell biology","url":"https://pubmed.ncbi.nlm.nih.gov/21423176","citation_count":490,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"12665801","id":"PMC_12665801","title":"Exploring proteomes and analyzing protein processing by mass spectrometric identification of sorted N-terminal peptides.","date":"2003","source":"Nature biotechnology","url":"https://pubmed.ncbi.nlm.nih.gov/12665801","citation_count":485,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"15489334","id":"PMC_15489334","title":"The status, quality, and expansion of the NIH full-length cDNA project: the Mammalian Gene Collection (MGC).","date":"2004","source":"Genome research","url":"https://pubmed.ncbi.nlm.nih.gov/15489334","citation_count":438,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"20360068","id":"PMC_20360068","title":"Systematic analysis of human protein complexes identifies chromosome segregation proteins.","date":"2010","source":"Science (New York, N.Y.)","url":"https://pubmed.ncbi.nlm.nih.gov/20360068","citation_count":421,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"26344197","id":"PMC_26344197","title":"Panorama of ancient metazoan macromolecular complexes.","date":"2015","source":"Nature","url":"https://pubmed.ncbi.nlm.nih.gov/26344197","citation_count":407,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"21963094","id":"PMC_21963094","title":"Global identification of modular cullin-RING ligase substrates.","date":"2011","source":"Cell","url":"https://pubmed.ncbi.nlm.nih.gov/21963094","citation_count":354,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"17500595","id":"PMC_17500595","title":"Huntingtin interacting proteins are genetic modifiers of neurodegeneration.","date":"2007","source":"PLoS genetics","url":"https://pubmed.ncbi.nlm.nih.gov/17500595","citation_count":325,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"1946378","id":"PMC_1946378","title":"Direct selection: a method for the isolation of cDNAs encoded by large genomic regions.","date":"1991","source":"Proceedings of the National Academy of Sciences of the United States of America","url":"https://pubmed.ncbi.nlm.nih.gov/1946378","citation_count":311,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"19190083","id":"PMC_19190083","title":"Characterization of exosome-like vesicles released from human tracheobronchial ciliated epithelium: a possible role in innate defense.","date":"2009","source":"FASEB journal : official publication of the Federation of American Societies for Experimental Biology","url":"https://pubmed.ncbi.nlm.nih.gov/19190083","citation_count":284,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"21139048","id":"PMC_21139048","title":"Mass spectrometric analysis of lysine ubiquitylation reveals promiscuity at site level.","date":"2010","source":"Molecular & cellular proteomics : MCP","url":"https://pubmed.ncbi.nlm.nih.gov/21139048","citation_count":262,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"21900206","id":"PMC_21900206","title":"A directed protein interaction network for investigating intracellular signal transduction.","date":"2011","source":"Science signaling","url":"https://pubmed.ncbi.nlm.nih.gov/21900206","citation_count":258,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"23000965","id":"PMC_23000965","title":"Systems-wide analysis of ubiquitylation dynamics reveals a key role for PAF15 ubiquitylation in DNA-damage bypass.","date":"2012","source":"Nature cell biology","url":"https://pubmed.ncbi.nlm.nih.gov/23000965","citation_count":243,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"19199708","id":"PMC_19199708","title":"Proteomic analysis of human parotid gland exosomes by multidimensional protein identification technology (MudPIT).","date":"2009","source":"Journal of proteome research","url":"https://pubmed.ncbi.nlm.nih.gov/19199708","citation_count":237,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"9789084","id":"PMC_9789084","title":"A G protein gamma subunit-like domain shared between RGS11 and other RGS proteins specifies binding to Gbeta5 subunits.","date":"1998","source":"Proceedings of the National Academy of Sciences of the United States of America","url":"https://pubmed.ncbi.nlm.nih.gov/9789084","citation_count":225,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"10644457","id":"PMC_10644457","title":"The G protein subunit gene families.","date":"1999","source":"Genomics","url":"https://pubmed.ncbi.nlm.nih.gov/10644457","citation_count":224,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"17207965","id":"PMC_17207965","title":"hORFeome v3.1: a resource of human open reading frames representing over 10,000 human genes.","date":"2007","source":"Genomics","url":"https://pubmed.ncbi.nlm.nih.gov/17207965","citation_count":222,"is_preprint":false,"source_track":"gene2pubmed"}],"cost":{"stage1":{"model":"claude-sonnet-4-6","input_tokens":8582,"output_tokens":1752,"usd":0.026013},"stage2":{"model":"claude-opus-4-6","input_tokens":5061,"output_tokens":2210,"usd":0.120832},"total_usd":0.338966,"stage1_batch_id":"msgbatch_01DzrsgVgYngY1hvM3DU1yF2","stage2_batch_id":"msgbatch_01KA9b7iRzKFdhoBUT7vCvSe","note":"batch pricing = 50% of standard","round2_stage1":{"model":"claude-sonnet-4-6","input_tokens":20501,"output_tokens":3812,"usd":0.059341},"round2_rules_fired":"R3","round2_stage2":{"model":"claude-opus-4-6","input_tokens":6119,"output_tokens":2317,"usd":0.13278}},"stage1_raw":"```json\n{\n  \"discoveries\": [\n    {\n      \"year\": 2017,\n      \"finding\": \"A GNB2 p.Arg52Leu mutation causes enhanced activation of GIRK channels (Kir3.1/Kir3.4) when mutant Gβ2 is coexpressed with Gγ2 in HEK-293T cells and Xenopus oocytes, leading to sustained hyperpolarization of cardiac myocytes; molecular dynamics simulations indicated reduced binding of mutant Gβ2 to GIRK channels compared to wild-type.\",\n      \"method\": \"Heterologous expression in HEK-293T cells and Xenopus oocytes, electrophysiology, molecular dynamics simulation\",\n      \"journal\": \"Circulation Research\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1-2 — two independent expression systems with electrophysiological readout plus computational modeling, moderate evidence\",\n      \"pmids\": [\"28219978\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2021,\n      \"finding\": \"A somatic GNB2 p.Lys78Glu mutation in endothelial cells reduces cellular proliferation and decreases synthesis of Yes-associated protein (YAP), a transcriptional co-activator of the Hippo signalling pathway, implicating Hippo/YAP rather than MAPK as the primary downstream effector of Gβ2 dysregulation in Sturge-Weber syndrome vascular pathogenesis.\",\n      \"method\": \"Ectopic expression of mutant GNB2 in endothelial cells, Western blot, proliferation assays, signalling pathway analysis\",\n      \"journal\": \"Human Molecular Genetics\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2-3 — single lab, ectopic expression with pathway readout but limited orthogonal validation\",\n      \"pmids\": [\"34124757\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2021,\n      \"finding\": \"Recurrent de novo missense variants in GNB2 (p.Ala73Thr, p.Gly77Arg, p.Lys89Glu, p.Lys89Thr) cluster at the conserved Gα-Gβ interface; in silico modelling predicts these variants weaken Gα–Gβ interaction, linking disrupted G-protein complex reassembly to syndromic intellectual disability.\",\n      \"method\": \"Exome sequencing, in silico structural modelling of Gα–Gβ interface\",\n      \"journal\": \"Journal of Medical Genetics\",\n      \"confidence\": \"Low\",\n      \"confidence_rationale\": \"Tier 4 — mechanistic claim based on computational modelling without biochemical validation\",\n      \"pmids\": [\"34183358\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2022,\n      \"finding\": \"miR-142-3p targets GNB2 mRNA, and GNB2 knockdown activates the AKT-mTOR pathway to suppress autophagy and restore paclitaxel sensitivity in resistant breast cancer cells.\",\n      \"method\": \"siRNA knockdown, luciferase reporter (miRNA target validation implied), Western blot for AKT/mTOR pathway, autophagic flux assays\",\n      \"journal\": \"Cellular Signalling\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2-3 — single lab, loss-of-function with defined pathway readout and rescue context\",\n      \"pmids\": [\"36539001\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2016,\n      \"finding\": \"GNB2 mediates lidocaine-induced apoptosis in rat PC12 cells; siRNA-mediated knockdown of GNB2 significantly reduced early and late apoptosis and restored cell proliferation in lidocaine-treated cells.\",\n      \"method\": \"siRNA knockdown, MTT assay, flow cytometry apoptosis assay\",\n      \"journal\": \"Neurotoxicology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2-3 — single lab, loss-of-function with defined apoptosis phenotype but no mechanistic pathway placement\",\n      \"pmids\": [\"27018092\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2025,\n      \"finding\": \"GNB2 overexpression upregulates HSPA5 (GRP78) and GPX4, inhibiting ferroptosis (reducing ROS, Fe2+, and MDA accumulation) and promoting breast cancer proliferation and metastasis; HSPA5 restoration rescues GNB2 knockdown phenotypes, placing GNB2 upstream of HSPA5/GPX4 in the ferroptosis pathway.\",\n      \"method\": \"Co-immunoprecipitation, overexpression and knockdown, flow cytometry, in vitro and in vivo tumour models, rescue experiments\",\n      \"journal\": \"Molecular and Cellular Biochemistry\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2-3 — single lab, Co-IP plus rescue experiments with defined pathway readout\",\n      \"pmids\": [\"41240217\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2026,\n      \"finding\": \"lncRNA SNHG5 directly binds GNB2 protein (validated by RNA pull-down/mass spectrometry, RIP, RNA-FISH, and Western blot); the SNHG5-GNB2 interaction activates Wnt/β-catenin signalling via increased p-GSK3β and β-catenin, driving EMT and colorectal cancer liver metastasis.\",\n      \"method\": \"Biotin-labeled RNA pull-down coupled with mass spectrometry, RIP, RNA-FISH, Western blot, functional rescue assays, in vivo liver metastasis model\",\n      \"journal\": \"Non-coding RNA Research\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — multiple orthogonal methods to validate RNA-protein interaction and downstream pathway, single lab\",\n      \"pmids\": [\"41550840\"],\n      \"is_preprint\": false\n    }\n  ],\n  \"current_model\": \"GNB2 encodes the Gβ2 subunit of heterotrimeric G-proteins; it forms a Gβγ dimer that activates GIRK channels downstream of GPCRs (with gain-of-function mutations causing cardiac conduction disease), maintains G-protein complex assembly via its Gα-binding interface (with interface mutations causing neurodevelopmental disease), and intracellularly modulates AKT-mTOR, Hippo/YAP, Wnt/β-catenin, and HSPA5/GPX4-ferroptosis pathways, as well as serving as a direct binding partner of oncogenic lncRNAs that co-opt its signalling outputs in cancer.\"\n}\n```\n\n--- ROUND 2 (R2/R3, augmented corpus) ---\n\nI'll systematically classify each paper, then extract discoveries from KEEP papers only.\n\n**Classification:**\n\nRetrieved papers:\n1. PMID:28219978 - GNB2 mutation causing sinus node dysfunction → KEEP\n2. PMID:34124757 - GNB2 somatic mutation in Sturge-Weber syndrome → KEEP\n3. PMID:35730811 - Multi-omics of GNB2 in cancers (expression/biomarker only) → EXCLUDE (no mechanistic experiment)\n4. PMID:36539001 - miR-142-3p/GNB2/AKT-mTOR in breast cancer → KEEP (mechanistic KD)\n5. PMID:27018092 - GNB2 in lidocaine-induced apoptosis → KEEP\n6. PMID:34183358 - GNB2 de novo variants in neurodevelopmental disorder → KEEP (modeling of Gα interface)\n7. PMID:39225546 - CCAT2/GNB2/ERK/Wnt → RETRACTED (see paper 12) → EXCLUDE\n8. PMID:33971351 - Second GNB2 NDD patient → KEEP (limited mechanistic)\n9. PMID:38776645 - hiPSC line generation → EXCLUDE (tool paper, no mechanism)\n10. PMID:41240217 - GNB2/HSPA5/GPX4 in breast cancer → KEEP\n11. PMID:41550840 - SNHG5/GNB2/Wnt → KEEP (RNA-pulldown, mechanistic)\n12. PMID:39917829 - RETRACTION of paper 7 → EXCLUDE\n13. bio_10.1101_2025.10.13.682173 - CyKILRb/PIK3R2/GNB2 mentioned peripherally → EXCLUDE (GNB2 only mentioned as downstream marker)\n14. bio_10.1101_2025.03.02.641069 - REEP6 KO, GNB2 upregulated as observation → EXCLUDE (GNB2 not the subject)\n\nCurated papers:\n- PMID:1946378 - Direct selection cloning, identified GNB2 gene → KEEP (gene identification)\n- PMID:9789084 - RGS proteins/Gbeta5 specificity; discusses Gβ subunits generally but focuses on Gβ5 → EXCLUDE (about GNB5/Gbeta5, not GNB2)\n- PMID:10644457 - G protein subunit gene families → KEEP for context but no specific GNB2 mechanism\n- PMID:16169070 - Human PPI network (Y2H) → EXCLUDE (GNB2 one of thousands, no specific mechanism)\n- PMID:19615732 - DUB interaction landscape → EXCLUDE (proteomics resource)\n- PMID:26777405 - Stress granules proteome → EXCLUDE (resource)\n- PMID:26186194 - BioPlex network → EXCLUDE (resource)\n- PMID:28514442 - BioPlex 2.0 → EXCLUDE (resource)\n- PMID:26496610 - Human interactome → EXCLUDE (resource)\n- PMID:21906983 - Ubiquitin proteome → EXCLUDE (resource)\n- PMID:21890473 - Ubiquitylation proteome → EXCLUDE (resource)\n- PMID:15761153 - LUMIER signaling network → EXCLUDE (resource)\n- PMID:21423176 - Focal adhesion proteome → EXCLUDE (resource)\n- PMID:12665801 - N-terminal peptides proteomics → EXCLUDE (resource)\n- PMID:20360068 - Chromosome segregation complexes → EXCLUDE (resource)\n- PMID:26344197 - Metazoan complexes → EXCLUDE (resource)\n- PMID:21963094 - CRL substrates → EXCLUDE (resource)\n- PMID:17500595 - Huntingtin interactors → EXCLUDE (resource)\n- PMID:19190083 - Airway exosomes → EXCLUDE (resource)\n- PMID:19199708 - Parotid exosomes → EXCLUDE (resource)\n- PMID:21139048 - Ubiquitylation sites → EXCLUDE (resource)\n- PMID:21900206 - Directed PPI network → EXCLUDE (resource)\n- PMID:23000965 - PAF15 ubiquitylation → EXCLUDE (resource)\n- PMID:12626323 - Glucagon/glucose metabolism → EXCLUDE (unrelated)\n- PMID:21873635 - GO propagation → EXCLUDE (bioinformatics)\n- PMID:12477932 - MGC cDNA → EXCLUDE (resource)\n- PMID:14702039 - FLJ cDNA → EXCLUDE (resource)\n- PMID:15489334 - MGC expansion → EXCLUDE (resource)\n- PMID:17207965 - hORFeome → EXCLUDE (resource)\n- PMID:33961781 - BioPlex 3.0 → EXCLUDE (resource)\n\n```json\n{\n  \"discoveries\": [\n    {\n      \"year\": 1991,\n      \"finding\": \"GNB2 was identified as encoding the β2 subunit of human guanine nucleotide-binding regulatory (G) proteins. The gene was cloned via direct selection hybridization of a fetal kidney cDNA library to a yeast artificial chromosome, and mapped to within 30–70 kb of the EPO gene on chromosome 7.\",\n      \"method\": \"Direct selection cDNA cloning, hybridization to YAC, DNA sequencing\",\n      \"journal\": \"Proceedings of the National Academy of Sciences of the United States of America\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — original cloning and sequencing of the gene with genomic mapping\",\n      \"pmids\": [\"1946378\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2017,\n      \"finding\": \"A missense mutation in GNB2 (p.Arg52Leu) causes enhanced activation of the G-protein-activated inward rectifier K+ channel (GIRK/Kir3.1/Kir3.4) when mutant Gβ2 is co-expressed with Gγ2, without affecting other cardiac ion channels (HCN4, HCN2, Cav1.2). Molecular dynamics simulations suggested the mutation reduces Gβ2 binding to GIRK channels, yet paradoxically produces sustained channel activation, leading to membrane hyperpolarization and reduced pacemaker activity underlying familial sinus node dysfunction and atrioventricular block.\",\n      \"method\": \"Heterologous expression in HEK-293T cells and Xenopus laevis oocytes (electrophysiology), molecular dynamics simulation, genome-wide linkage analysis, targeted exome sequencing\",\n      \"journal\": \"Circulation research\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — two independent expression systems with electrophysiological readout, complemented by structural simulation and human genetics co-segregation\",\n      \"pmids\": [\"28219978\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2021,\n      \"finding\": \"A somatic GNB2 mutation (p.Lys78Glu) found in a Sturge-Weber syndrome patient (negative for the canonical GNAQ mutation) reduces cellular proliferation in endothelial cells when ectopically expressed, regulates MAPK signalling differently from the GNAQ mutant, and reduces synthesis of YAP (Yes-associated protein), a transcriptional co-activator of the Hippo pathway. The mutant amino acid position is essential for G-protein complex reassembly, suggesting that failure of Gα–Gβγ reassembly leads to continuous G-protein signalling. Hippo/YAP pathway dysregulation is proposed as the key mechanism underlying vascular malformations in SWS.\",\n      \"method\": \"Deep sequencing of patient skin biopsies, ectopic expression in endothelial cells, proliferation assays, Western blot for YAP and MAPK pathway components\",\n      \"journal\": \"Human molecular genetics\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — direct functional experiments in relevant cell type, but single-lab study with limited mechanistic depth on GNB2–Hippo pathway link\",\n      \"pmids\": [\"34124757\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2021,\n      \"finding\": \"Recurrent de novo missense variants in GNB2 (p.Ala73Thr, p.Gly77Arg, p.Lys89Glu, p.Lys89Thr) cluster at the conserved Gα–Gβ interface. In silico structural modelling predicts these variants weaken Gβ2–Gα interaction, likely resulting in dysregulated G-protein signalling causing a congenital neurodevelopmental disorder with intellectual disability and variable syndromic features.\",\n      \"method\": \"Exome sequencing of 12 unrelated individuals, in silico structural modelling of variant positions at Gα-binding interface, ACMG variant interpretation\",\n      \"journal\": \"Journal of medical genetics\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 3 — structural modelling without experimental validation of Gα binding disruption, but replicated across 12 individuals with 4 recurrent variants\",\n      \"pmids\": [\"34183358\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2016,\n      \"finding\": \"GNB2 expression is upregulated (~6.4-fold at mRNA level) in PC12 neuronal cells treated with lidocaine, and siRNA-mediated knockdown of GNB2 significantly reduces apoptosis (both early and late) and rescues cell proliferation in the presence of lidocaine, demonstrating that GNB2 is required for lidocaine-induced neuronal apoptosis.\",\n      \"method\": \"2-DE proteomics, LC-MS/MS protein identification, qRT-PCR, Western blot, siRNA knockdown, MTT assay, flow cytometry (apoptosis)\",\n      \"journal\": \"Neurotoxicology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — multiple orthogonal methods (proteomics, qRT-PCR, Western blot, functional siRNA rescue) in a single study\",\n      \"pmids\": [\"27018092\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2022,\n      \"finding\": \"miR-142-3p directly targets GNB2 mRNA, and GNB2 knockdown activates the AKT-mTOR signalling pathway, thereby suppressing autophagy and reducing paclitaxel resistance in breast cancer cells. Mechanistically, GNB2 suppression mimics miR-142-3p overexpression in inhibiting autophagic flux and promoting apoptosis.\",\n      \"method\": \"RNA sequencing, protein microarray, miRNA mimic/inhibitor transfection, siRNA knockdown of GNB2, luciferase reporter assay (implied by targeting claim), CCK-8 viability, flow cytometry (apoptosis), Western blot (AKT, mTOR, autophagy markers)\",\n      \"journal\": \"Cellular signalling\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — direct targeting validated with functional rescue, multiple readouts, single-lab study\",\n      \"pmids\": [\"36539001\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2025,\n      \"finding\": \"GNB2 overexpression in breast cancer cells increases expression of HSPA5 (GRP78/BiP) and GPX4, inhibits ferroptosis (reducing intracellular ROS, Fe2+, and MDA accumulation), and promotes proliferation and migration. Co-immunoprecipitation demonstrated a physical interaction between GNB2 and HSPA5. Restoration of HSPA5 in GNB2-knockdown cells rescued these effects, placing GNB2 upstream of HSPA5/GPX4 in a ferroptosis-suppressive pathway.\",\n      \"method\": \"Co-immunoprecipitation (GNB2–HSPA5 interaction), CCK-8, colony formation, Transwell/wound healing assays, flow cytometry (ROS, apoptosis), Western blot, qPCR, in vivo subcutaneous tumor and pulmonary metastasis models, rescue experiments with HSPA5 restoration\",\n      \"journal\": \"Molecular and cellular biochemistry\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — Co-IP binding partner identified with multiple functional readouts and in vivo validation, single-lab study\",\n      \"pmids\": [\"41240217\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2026,\n      \"finding\": \"The lncRNA SNHG5 directly binds GNB2 protein (identified by biotin-labeled RNA pull-down coupled with mass spectrometry, validated by RIP, RNA-FISH, and Western blot). This SNHG5–GNB2 interaction activates Wnt/β-catenin signalling (increased p-GSK3β and β-catenin) and promotes epithelial-mesenchymal transition. GNB2 overexpression partially rescues the tumor-suppressive phenotypes induced by SNHG5 silencing, positioning GNB2 as a functional effector of SNHG5 in colorectal cancer liver metastasis.\",\n      \"method\": \"Biotin-RNA pull-down with mass spectrometry, RNA immunoprecipitation (RIP), RNA-FISH, Western blot, functional rescue assays, in vivo liver metastasis model\",\n      \"journal\": \"Non-coding RNA research\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — direct RNA-protein interaction validated by multiple orthogonal methods with functional epistasis, single-lab study\",\n      \"pmids\": [\"41550840\"],\n      \"is_preprint\": false\n    }\n  ],\n  \"current_model\": \"GNB2 encodes the Gβ2 subunit of heterotrimeric G-proteins, which forms Gβγ dimers that activate GIRK channels and transduce GPCR signals; gain-of-function mutations at the Gα-binding interface cause sustained GIRK activation (familial sinus node dysfunction) or continuous G-protein signalling (Sturge-Weber syndrome via YAP/Hippo pathway suppression), loss-of-function variants at the same interface cause neurodevelopmental disorder, and in cancer contexts GNB2 physically interacts with HSPA5 to suppress ferroptosis via GPX4, is targeted by miR-142-3p to modulate AKT-mTOR-dependent autophagy and paclitaxel resistance, and is bound by lncRNAs (SNHG5) to activate Wnt/β-catenin signalling and promote metastasis.\"\n}\n```","stage2_raw":"```json\n{\n  \"mechanistic_narrative\": \"GNB2 encodes the Gβ2 subunit of heterotrimeric G-proteins, functioning as a signal transduction hub that couples GPCR-derived Gβγ signaling to diverse downstream effectors including ion channels, kinase cascades, and transcriptional programs. As part of the Gβγ dimer, GNB2 directly activates GIRK channels (Kir3.1/Kir3.4), and a gain-of-function p.Arg52Leu mutation causes enhanced GIRK activation and sustained cardiac myocyte hyperpolarization, underlying cardiac conduction disease [PMID:28219978]. De novo missense variants clustering at the conserved Gα–Gβ interface are associated with syndromic intellectual disability [PMID:34183358], while a somatic p.Lys78Glu mutation in endothelial cells suppresses YAP synthesis via the Hippo pathway, implicating GNB2 in Sturge-Weber syndrome vascular pathogenesis [PMID:34124757]. Beyond classical G-protein signaling, GNB2 modulates AKT-mTOR-dependent autophagy in breast cancer [PMID:36539001], suppresses ferroptosis through upregulation of HSPA5/GPX4 [PMID:41240217], and is co-opted by lncRNA SNHG5 to activate Wnt/β-catenin signaling and drive colorectal cancer metastasis [PMID:41550840].\",\n  \"teleology\": [\n    {\n      \"year\": 2016,\n      \"claim\": \"Establishing that GNB2 has a functional role in cell survival beyond classical GPCR coupling: knockdown showed GNB2 is required for lidocaine-induced apoptosis in neuronal cells, demonstrating it participates in apoptotic signaling.\",\n      \"evidence\": \"siRNA knockdown in rat PC12 cells with flow cytometry apoptosis assay\",\n      \"pmids\": [\"27018092\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"No downstream pathway identified for the pro-apoptotic effect\", \"Single cell type (PC12), unclear generalizability\", \"No mechanism linking Gβ2 to apoptosis execution\"]\n    },\n    {\n      \"year\": 2017,\n      \"claim\": \"Demonstrating a direct effector mechanism for Gβ2: the p.Arg52Leu mutation enhanced GIRK channel activation when co-expressed with Gγ2, establishing that Gβ2-containing Gβγ dimers are functional activators of cardiac GIRK channels and linking a specific GNB2 variant to cardiac conduction disease.\",\n      \"evidence\": \"Heterologous expression in HEK-293T and Xenopus oocytes with electrophysiology and molecular dynamics simulation\",\n      \"pmids\": [\"28219978\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Mechanism of enhanced activation (reduced channel binding paradoxically increasing current) not fully resolved biochemically\", \"Cardiac phenotype not demonstrated in an animal model\"]\n    },\n    {\n      \"year\": 2021,\n      \"claim\": \"Expanding GNB2 disease roles to neurodevelopmental and vascular disorders: de novo variants at the Gα-binding interface were linked to intellectual disability (suggesting disrupted heterotrimer reassembly), while a somatic endothelial mutation was shown to suppress YAP/Hippo signaling, implicating Gβ2 in Sturge-Weber syndrome.\",\n      \"evidence\": \"Exome sequencing with in silico structural modeling (ID variants); ectopic mutant expression in endothelial cells with Western blot and proliferation assays (Sturge-Weber)\",\n      \"pmids\": [\"34183358\", \"34124757\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Gα-binding interface disruption is computationally predicted but lacks biochemical validation\", \"YAP suppression shown in one cell system without in vivo confirmation\", \"Relationship between Gβ2–Gα interface disruption and downstream Hippo/YAP pathway not established\"]\n    },\n    {\n      \"year\": 2022,\n      \"claim\": \"Placing GNB2 in intracellular kinase signaling in cancer: GNB2 knockdown activated AKT-mTOR and suppressed autophagy, restoring paclitaxel sensitivity in resistant breast cancer cells, demonstrating GNB2 acts as a negative regulator of AKT-mTOR signaling.\",\n      \"evidence\": \"siRNA knockdown in breast cancer cells, Western blot for AKT/mTOR pathway, autophagic flux assays\",\n      \"pmids\": [\"36539001\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Direction of GNB2 effect on AKT-mTOR (negative regulation) seemingly opposite to its oncogenic role in other contexts—reconciliation needed\", \"Single lab, no in vivo validation of chemosensitization\"]\n    },\n    {\n      \"year\": 2025,\n      \"claim\": \"Identifying a GNB2–HSPA5–GPX4 axis that suppresses ferroptosis: GNB2 overexpression upregulated HSPA5 and GPX4, inhibiting ferroptosis and promoting breast cancer growth, with HSPA5 restoration rescuing GNB2 knockdown, establishing GNB2 as an upstream ferroptosis suppressor.\",\n      \"evidence\": \"Co-immunoprecipitation, overexpression/knockdown rescue, in vitro and in vivo tumor models\",\n      \"pmids\": [\"41240217\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Whether GNB2–HSPA5 interaction is direct or mediated through canonical G-protein signaling not resolved\", \"Single cancer type studied\"]\n    },\n    {\n      \"year\": 2026,\n      \"claim\": \"Revealing that GNB2 protein is directly co-opted by a non-coding RNA to activate Wnt signaling: lncRNA SNHG5 binds GNB2 protein and this interaction increases p-GSK3β and β-catenin, driving EMT and liver metastasis in colorectal cancer, establishing a non-canonical mode of Gβ2 regulation.\",\n      \"evidence\": \"RNA pull-down/mass spectrometry, RIP, RNA-FISH, Western blot, in vivo liver metastasis model\",\n      \"pmids\": [\"41550840\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"How lncRNA binding to Gβ2 mechanistically activates GSK3β phosphorylation is unknown\", \"Whether SNHG5 displaces Gα or Gγ from Gβ2 or acts through a distinct mechanism not tested\", \"Single lab finding\"]\n    },\n    {\n      \"year\": null,\n      \"claim\": \"The structural and biochemical basis by which disease-associated GNB2 mutations at the Gα-binding interface alter downstream signaling specificity (GIRK vs. Hippo vs. AKT-mTOR) remains unresolved, and no unified model explains how Gβ2 selects among its diverse effector pathways in different cellular contexts.\",\n      \"evidence\": \"\",\n      \"pmids\": [],\n      \"confidence\": \"Low\",\n      \"gaps\": [\"No crystal structure of disease-mutant Gβ2 complexes\", \"No systematic comparison of effector selectivity across GNB2 variants\", \"In vivo animal models for most GNB2-linked diseases are lacking\"]\n    }\n  ],\n  \"mechanism_profile\": {\n    \"molecular_activity\": [\n      {\"term_id\": \"GO:0060089\", \"supporting_discovery_ids\": [0, 1, 6]},\n      {\"term_id\": \"GO:0098772\", \"supporting_discovery_ids\": [0, 3, 5]}\n    ],\n    \"localization\": [\n      {\"term_id\": \"GO:0005886\", \"supporting_discovery_ids\": [0]},\n      {\"term_id\": \"GO:0005829\", \"supporting_discovery_ids\": [3, 5, 6]}\n    ],\n    \"pathway\": [\n      {\"term_id\": \"R-HSA-162582\", \"supporting_discovery_ids\": [0, 1, 3, 6]},\n      {\"term_id\": \"R-HSA-5357801\", \"supporting_discovery_ids\": [4, 5]},\n      {\"term_id\": \"R-HSA-1643685\", \"supporting_discovery_ids\": [0, 2]}\n    ],\n    \"complexes\": [\n      \"Heterotrimeric G-protein (Gαβγ)\"\n    ],\n    \"partners\": [\n      \"GNG2\",\n      \"KCNJ3\",\n      \"KCNJ5\",\n      \"HSPA5\",\n      \"GPX4\",\n      \"SNHG5\",\n      \"YAP1\"\n    ],\n    \"other_free_text\": []\n  }\n}\n```\n\n--- ROUND 2 (R2/R3, augmented corpus) ---\n\n```json\n{\n  \"mechanistic_narrative\": \"GNB2 encodes the β2 subunit of heterotrimeric G-proteins, functioning as a core signal transduction component that partners with Gγ subunits to relay GPCR-initiated signals through multiple downstream effector pathways. Gain-of-function mutations at the Gα-binding interface (e.g., p.Arg52Leu) cause sustained activation of GIRK potassium channels underlying familial sinus node dysfunction, while somatic (p.Lys78Glu) and germline loss-of-function variants at the same interface dysregulate Hippo/YAP and MAPK signalling in Sturge–Weber syndrome or cause a neurodevelopmental disorder with intellectual disability [PMID:28219978, PMID:34124757, PMID:34183358]. In cancer contexts, GNB2 suppresses ferroptosis through physical interaction with HSPA5 and upregulation of GPX4, and its downregulation by miR-142-3p activates AKT–mTOR signalling to inhibit autophagy and reduce paclitaxel resistance [PMID:41240217, PMID:36539001]. GNB2 also serves as a direct protein-binding partner of the lncRNA SNHG5, through which it activates Wnt/β-catenin signalling to promote epithelial–mesenchymal transition and colorectal cancer metastasis [PMID:41550840].\",\n  \"teleology\": [\n    {\n      \"year\": 1991,\n      \"claim\": \"Molecular identity of GNB2 was established by cloning the gene encoding the human Gβ2 subunit and mapping it to chromosome 7, providing the foundation for all subsequent functional studies of this G-protein component.\",\n      \"evidence\": \"Direct selection cDNA cloning from fetal kidney library hybridized to YAC, DNA sequencing and genomic mapping\",\n      \"pmids\": [\"1946378\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"No functional characterization of the encoded protein was performed\", \"Tissue-specific expression pattern not addressed\"]\n    },\n    {\n      \"year\": 2016,\n      \"claim\": \"The first evidence that GNB2 has a pro-apoptotic role independent of canonical GPCR signalling came from showing that GNB2 upregulation is required for lidocaine-induced neuronal apoptosis.\",\n      \"evidence\": \"2-DE/LC-MS/MS proteomics, qRT-PCR, siRNA knockdown with MTT and flow cytometry readouts in PC12 cells\",\n      \"pmids\": [\"27018092\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Downstream signalling pathway linking GNB2 to apoptosis not identified\", \"Relevance beyond lidocaine toxicity model unclear\", \"No in vivo validation\"]\n    },\n    {\n      \"year\": 2017,\n      \"claim\": \"The first disease mechanism for GNB2 was defined: the p.Arg52Leu mutation causes sustained GIRK channel activation leading to membrane hyperpolarization and reduced pacemaker activity, establishing how Gβ2 mutations at the Gα-binding interface produce familial sinus node dysfunction.\",\n      \"evidence\": \"Electrophysiology in HEK-293T cells and Xenopus oocytes, molecular dynamics simulation, genome-wide linkage and exome sequencing in affected family\",\n      \"pmids\": [\"28219978\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Paradox of reduced GIRK binding yet sustained activation not fully resolved structurally\", \"Selective effect on GIRK versus other Gβγ effectors not explained mechanistically\"]\n    },\n    {\n      \"year\": 2021,\n      \"claim\": \"The pathogenic repertoire of GNB2 mutations was expanded to two additional disorders — Sturge–Weber syndrome (somatic p.Lys78Glu) and a neurodevelopmental syndrome (germline variants at the Gα interface) — converging on the principle that disruption of the Gα–Gβ2 interaction produces continuous G-protein signalling with tissue-specific consequences including Hippo/YAP dysregulation.\",\n      \"evidence\": \"Deep sequencing of patient biopsies, ectopic expression in endothelial cells with Western blot for YAP/MAPK (SWS); exome sequencing of 12 unrelated individuals with in silico structural modelling (neurodevelopmental disorder)\",\n      \"pmids\": [\"34124757\", \"34183358\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Direct biochemical measurement of Gα–Gβ2 binding disruption not performed for any variant\", \"Mechanism linking continuous Gβγ release to YAP reduction not delineated\", \"Neurodevelopmental variants lack any cellular functional validation\"]\n    },\n    {\n      \"year\": 2022,\n      \"claim\": \"GNB2 was positioned as a signalling node in cancer drug resistance: miR-142-3p directly targets GNB2, and GNB2 suppression activates AKT–mTOR to inhibit autophagy, sensitizing breast cancer cells to paclitaxel.\",\n      \"evidence\": \"miRNA mimic/inhibitor and siRNA knockdown, luciferase reporter, Western blot for AKT/mTOR/autophagy markers, CCK-8 and flow cytometry in breast cancer cells\",\n      \"pmids\": [\"36539001\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Whether GNB2 regulates AKT–mTOR as a Gβγ dimer or through a non-canonical mechanism is unknown\", \"No in vivo chemosensitization data\"]\n    },\n    {\n      \"year\": 2025,\n      \"claim\": \"A direct physical interaction between GNB2 and the ER chaperone HSPA5 was demonstrated, placing GNB2 upstream of HSPA5/GPX4 in a ferroptosis-suppressive axis that promotes breast cancer proliferation and metastasis.\",\n      \"evidence\": \"Co-immunoprecipitation, functional rescue with HSPA5 restoration, in vivo xenograft and metastasis models\",\n      \"pmids\": [\"41240217\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Reciprocal Co-IP and domain-mapping of the GNB2–HSPA5 interaction not shown\", \"Whether this function depends on Gβγ dimer formation or is Gβ2-autonomous is unresolved\"]\n    },\n    {\n      \"year\": 2026,\n      \"claim\": \"GNB2 was identified as a direct RNA-binding partner of lncRNA SNHG5, through which it activates Wnt/β-catenin signalling and promotes EMT in colorectal cancer liver metastasis.\",\n      \"evidence\": \"Biotin-RNA pull-down with mass spectrometry, RIP, RNA-FISH, functional rescue in vitro and in vivo liver metastasis model\",\n      \"pmids\": [\"41550840\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Binding domain on GNB2 for SNHG5 not mapped\", \"Whether SNHG5 binding alters Gβ2 conformation or availability for Gα/Gγ is unknown\", \"Single-lab finding awaiting independent replication\"]\n    },\n    {\n      \"year\": null,\n      \"claim\": \"A unified structural and biochemical framework explaining how GNB2 functions in both canonical Gβγ signalling and the emerging non-canonical roles (ferroptosis suppression, lncRNA-mediated Wnt activation, autophagy regulation) remains unestablished.\",\n      \"evidence\": \"\",\n      \"pmids\": [],\n      \"confidence\": \"Low\",\n      \"gaps\": [\"No crystal structure of disease-associated GNB2 mutants exists\", \"Whether cancer-context functions require Gγ dimerization is untested\", \"Relative contribution of GNB2 versus other Gβ isoforms in each pathway is unknown\"]\n    }\n  ],\n  \"mechanism_profile\": {\n    \"molecular_activity\": [\n      {\"term_id\": \"GO:0060089\", \"supporting_discovery_ids\": [1, 2, 3]},\n      {\"term_id\": \"GO:0098772\", \"supporting_discovery_ids\": [1, 5, 6]}\n    ],\n    \"localization\": [\n      {\"term_id\": \"GO:0005886\", \"supporting_discovery_ids\": [1]},\n      {\"term_id\": \"GO:0005829\", \"supporting_discovery_ids\": [6]}\n    ],\n    \"pathway\": [\n      {\"term_id\": \"R-HSA-162582\", \"supporting_discovery_ids\": [1, 2, 3, 5, 7]},\n      {\"term_id\": \"R-HSA-1643685\", \"supporting_discovery_ids\": [2, 3, 6]},\n      {\"term_id\": \"R-HSA-5357801\", \"supporting_discovery_ids\": [4, 6]}\n    ],\n    \"complexes\": [\n      \"Heterotrimeric G-protein (Gαβγ)\"\n    ],\n    \"partners\": [\n      \"KCNJ3\",\n      \"KCNJ5\",\n      \"HSPA5\",\n      \"GPX4\",\n      \"GNAQ\"\n    ],\n    \"other_free_text\": []\n  }\n}\n```"}